Author: Urenus

Collagen + viola

Sterile vials

Intended use

• Improve movement of the small joints of hand, foot and ankle.
• Help muscle stretching.
• Help to support the muscle tissue.
• Soothe local pain and pain caused by joint movement.

Directions

Therapeutic protocol: 1 treatment weekly for 10 consecutive weeks.

Periarticular injection technique (the site of application must be aseptic; insert the needle near the sacroiliac joint at 2-4 mm depth)

For this purpose the use of the following materials and accessories is recommended:

• Materials for aseptic skin preparation: single-use gloves, iodine solution, alcohol solution, sterile gauze pads, ethyl chloride spray for the skin.
• Needles: sterile 27 G.
• Syringes: 5 or 10 cc size, according to the volume of the solution to inject.

Intraarticular injection technique

For this purpose the use of the following materials and accessories is recommended:

• Materials for aseptic skin preparation: single-use gloves, iodine solution, alcohol solution, sterile gauze pads, ethyl chloride spray for the skin. The application of a topical anaesthetic on the skin area to be treated is recommended.
• Needles: sterile 22 G.
• Syringes: 2 cc size, according to the volume of the solution to inject.

Ankle – Intraarticular approach

Medial approach. A 22 G needle is placed about 4 cm proximal and lateral to the distal end of the medial malleolus. The flexor hallucis longus tendon is just lateral to this point. The needle is directed 45 degrees posteriorly, slightly upward, and laterally.

Lateral approach. A 22 G needle is placed about 1 cm proximal and medial to the distal end of the lateral malleolus. The needle should be inserted 45 degrees posteriorly, slightly upward.

Instructions and possible combinations

MD-SMALL JOINTS may be used as a single treatment or mixed with other medical devices of the same range, in order to make a customised treatment according to clinical evolution.

When a supportive treatment is needed for acute pain, MD-SMALL JOINTS can be associated with MD-NEURAL, MD-POLY and MD-MUSCLE (together with one or more than one of these).

Moreover, when a supportive treatment is needed for the connective tissue matrix or when the physiological aging process should be slowed down, MD-SMALL JOINTS can be associated with MD-MATRIX and MD-TISSUE.

It may also be used as mechanical support while treating the following diseases:

• Osteoarthritis of the fingers
• Rhizoarthrosis of the thumb (Forestier disease)
• Arthrosis pain due to hammer toe
• Carpal-tunnel syndrome (in association with MD-NEURAL)
• De Quervain disease (in association with MD-NEURAL)
• Metatarsal pain
• Metatarsal pain accompanied by Morton’s neuroma (in association with MD-NEURAL)
• Rheumatoid arthritis of the hand/foot (in association with MD-POLY)
• Hand/Foot tendon pain due to prolonged immobilisation.

Product link: https://urenus.com/en-us/products/md-small-joints-pack-of-10-ampoules-of-2ml

Collagen + hypericum

Sterile vials

Intended use

• Help muscle stretching and function.
• Help to support the muscle tissue in bad posture disorders.
• Improve joint movement.
• Soothe local pain, or pain caused by movement and bad posture.

Directions

Therapeutic protocol: 1-2 treatments weekly for 10 consecutive weeks.

Intramuscular injection technique

(the site of application must be aseptic; insert the needle into the muscle to be treated at 2-4 mm depth)

For this purpose the use of the following materials and accessories is recommended:

• Materials for aseptic skin preparation: single-use gloves, iodine solution, alcohol solution, sterile gauze pads, ethyl chloride spray for the skin.
• Needles: sterile 27 G.
• Syringes: 5 or 10 cc size, according to the volume of the solution to inject.

Intramuscular injection technique

For this purpose the use of the following materials and accessories is recommended:

• Materials for aseptic skin preparation: single-use gloves, iodine solution, alcohol solution, sterile gauze pads, ethyl chloride spray for the skin. The application of a topical anaesthetic to the skin is recommended.
• Needles: sterile 22 G.
• Syringes: 2 cc size, according to the volume of the solution to inject.

Instructions and possible combinations

MD-MUSCLE may be used as a single treatment or mixed with other medical devices of the same range, in order to make a customised treatment according to clinical evolution.

When a supportive treatment is needed for the connective tissue matrix or when an antiaging action is necessary, MD-MUSCLE can be associated with MD-MATRIX and MD-TISSUE.

It may also be used as mechanical support while treating the following diseases:

• Pain management: acute, subacute, and chronic.
• Referred somatic pain area management (in association with MD-NEURAL)
• Trigger points management (in association with MD-NEURAL)
• Fibromyalgia syndrome (in association with MD-NEURAL)
• Dermatomyositis.

Administration may vary according to individual needs.

Product link: https://urenus.com/en-us/products/md-muscle-pack-of-10-ampoules-of-2ml

Collagen +iris

Sterile vials

Intended use

• Improve movement of the shoulder joint and the arm.
• Help muscle stretching.
• Help to support the muscle tissue.
• Soothe local pain and pain caused by movement.

Directions

Therapeutic protocol: 1-2 treatments weekly for 10 consecutive weeks.

Periarticular injection technique (the site of application must be aseptic; insert the needle at 2-4 mm depth).

For this purpose the use of the following materials and accessories is recommended:

• Materials for aseptic skin preparation: single-use gloves, iodine solution, alcohol solution, sterile gauze pads, ethyl chloride spray for the skin.
• Needles: sterile 27 G.
• Syringes: 5 or 10 cc size, according to the volume of the solution to inject.

Intraarticular injection technique

For this purpose the use of the following materials and accessories is recommended:

• Materials for aseptic skin preparation: single-use gloves, iodine solution, alcohol solution, sterile gauze pads, ethyl chloride spray for skin.The application of a topical anaesthetic on the skin area to be treated is recommended.
• Needles: sterile 22 G.
• Syringes: 2 cc size, according to the volume of the solution to inject.

Shoulder – Intraarticular injection, anterior approach

Anterior approach. With the patient’s hand on the thigh and the shoulder muscles relaxed, the glenohumeral joint can be palpated by placing the fingers between the coracoid process and the humeral head. As the shoulder is internally rotated, the humeral head can be felt turning inward and the joint space can be felt as a groove just lateral to the coracoid process. A 22 G needle can be inserted lateral to the coracoid. Insert the needle into the joint space.

Shoulder – Intraarticular injection, posterior approach

Posterior approach. The posterior aspect of the shoulder joint can be identified by making the patient’s arm rotate. This position is achieved by placing the patient’s ipsilateral hand on the opposite shoulder. The humeral head can be palpated by placing a finger posteriorly along the acromion while the shoulder is rotated. A 22 G needle is inserted about 1 cm inferior to the posterior tip of the acromion and directed anteriorly and medially.

Instructions and possible combinations

MD-SHOULDER may be used as a single treatment or mixed with other medical devices of the same range, in order to make a customised treatment according to clinical evolution.

When a supportive treatment is needed for acute pain, MD-SHOULDER can be associated with MD-NEURAL, MD-POLY and MD-MUSCLE (together with one or more than one of these).

Moreover, when a supportive treatment is needed for the connective tissue matrix or when the physiological aging process should be slowed down, MD-SHOULDER can be associated with MD-MATRIX and MD-TISSUE

It may also be used as mechanical support while treating the following diseases:

• Shoulder-arm polyarthritis (in association with MD-POLY)
• Rotator cuff syndrome (in association with MD-MUSCLE)
• Shoulder-arm syndrome (in association with MD-NEURAL and MD-MUSCLE)
• Frozen shoulder (in association with MD-MUSCLE)
• Shoulder pain due to dislocation (therapeutic rest, in association with MD-NEURAL)
• Epicondylitis (in association with MD-NEURAL and MD-POLY)

Product link: https://urenus.com/en-us/products/md-shoulder-pack-of-10-ampoules-of-2ml

(for males)

Composition

Gl. pinealis D6/12/30/200, Melatonin D6/12/30/200, Hypophysis suis D6/12/30/200, Hypothalamus suis D6/12/30/200, Gl. thyreoidea suis D6/12/30/200, Thymus suis D6/12/30/200, Pancreas suis D6/12/30/200, Testis suis D6/12/30/200, Gl. suprarenalis suis D6/12/30/200. Contains alcohol (30%).

Indications

For restoring neuroendocrine function in case of:

• andropause
• mood disorders
• neuroendocrine-related disorders in the sexual sphere

Dosage

10 drops 2-3 times a day.

Package size

30 ml bottle with drop counter. For oral use.

Product link: https://urenus.com/en-us/products/bone-health-d3-k2-minerals-60-capsules

Collagen + calcium phosphate

Sterile vials

Intended use

• Improve the movement of the hip joint.
• Help muscle stretching of the lumbosacral area.
• Support the periarticular muscle tissue.
• Sooth local pain, pain caused by joint movement or bad posture.

Directions

Therapeutic protocol: 1 treatment weekly for 10 consecutive weeks.

Periarticular injection technique

(the site of application must be aseptic; insert the needle at

6-8 mm depth)

For this purpose the use of the following materials and accessories is recommended:

• Materials for aseptic skin preparation: single-use gloves, iodine solution, alcohol solution, sterile gauze pads, ethyl chloride spray for the skin.
• Needles: sterile 27 G.
• Syringes: 5 or 10 cc size, according to the volume of the solution to inject.

Intraarticular injection technique

For this purpose the use of the following materials and accessories is recommended:

• Materials for aseptic skin preparation: single-use gloves, iodine solution, alcohol solution, sterile gauze pads, ethyl chloride spray for the skin. The application of a topical anaesthetic on the skin area to be treated is recommended.
• Needles: sterile 22 G.
• Syringes: 2 cc size, according to the volume of the solution to inject.

Hip – Intraarticular injection

The trochanteric bursa is located over the lateral prominence of the greater trochanter of the femur.

There can be an anterior or a lateral approach to the hip.

The patient is lying supine. The anatomic landmark is located 2 cm below the superior border of the greater trochanter in between its anterior and posterior borders. The skin overlying this location is marked and prepared in a sterile way. A 22 gauge needle is injected parallel to the floor and perpendicular to the femoral shaft.

Instructions and possible combinations

MD-HIP may be used as a single treatment or mixed with other medical devices of the same range in order to make a customised treatment according to clinical evolution.

When a supportive treatment is needed for acute pain, MD-HIP can be associated with MD-NEURAL, MD-POLY and MD-MUSCLE (together with one or more than one of these).

Moreover, when a supportive treatment is needed for the connective tissue matrix or when the physiological ageing process is needed to be slowed down, MD-HIP can be associated with MD-MATRIX and MD-TISSUE.

It may also be used as mechanical support while treating the following diseases:

• Hip joint osteoarthritis.
• Hip joint capsule inflammation.
• Hip joint osteoarthritis with rheumatoid arthritis (in association with MD-POLY).
• Hip joint pain of muscle origin (in association with MD-MUSCLE)
• Hip joint pain of nerve origin (burning hip, in association with MD-NEURAL)
• Hip joint pain due to prolonged bed rest.

Administration may vary according to individual needs.

Product link: https://urenus.com/en-us/products/md-hip-pack-of-10-ampoules-of-2ml

Collagen + silica

Sterile vials

Intended use

• Improve the movement of the cervical tract of the spine.
• Help cervical muscle stretching.
• Help to support cervical muscle tissue.
• Help to support cervical muscle tissue in bad posture disorders.
• Soothe pain in cervical column movements.

Directions

Therapeutic protocol: 1-2 treatments weekly for 10 consecutive weeks.

Periarticular injection technique (the site of application must be aseptic; insert the needle at 2-4 mm depth).

For this purpose the use of the following materials and accessories is recommended:

• Materials for aseptic skin preparation: single-use gloves, iodine solution, alcohol solution, sterile gauze pads, ethyl chloride spray for the skin.
• Needles: sterile 27 G.
• Syringes: 5 or 10 cc size, according to the volume of the solution to inject.

Instructions and possible combinations

MD-NECK may be used as a single treatment or mixed with other medical devices of the same range, in order to make a customised treatment according to clinical evolution.

When a supportive treatment is needed for acute pain, MD-NECK can be associated with MD-NEURAL, MD-POLY and

MD-MUSCLE (together with one or more than one of these). Moreover, when a supportive treatment is needed for the connective tissue matrix or when the physiological aging process should be slowed down, MD-NECK can be associated with MD-MATRIX and MD-TISSUE.

It may also be used as mechanical support while treating the following diseases:

• Neck pain due to cartilage degenerative cervical spine disorders (cervical osteoarthritis, in association with MD-POLY)
• Neck pain due to cervical muscular trigger points (in association with MD-MUSCLE)
• Stiff neck syndrome (in association with MD-NEURAL)
• Simple neck pain (in association with MD-NEURAL and MD-MUSCLE)
• Whiplash (in association with MD-NEURAL and MD-MUSCLE)
• Postural neck ache (in association with MD-NEURAL and MD-MUSCLE)
• Mechanical imbalance (facet joint syndrome) (in association with MD-NEURAL)
• Cervical spinal ligament syndrome (in association with MD-NEURAL)
• Cervical spinal nerve root pain (in association with MD-NEURAL).

Administration may vary according to individual needs.

Product link: https://urenus.com/en-us/products/md-neck-pack-of-10-ampoules-of-2ml

(for females)

Composition

Gl. pinealis suis D6, Melatonin D6, Hypophysis suis D6, Hypothalamus suis D6, Gl. thyreoidea suis D6, Thymus suis D6, Pancreas suis D6/30, Pancreas suis 200K, Ovarium suis D12/200, Corpus luteum suis D6/200, Hepar suis 200K, Cor suis 200K, Pulmo suis 200K, Zincum gluconicum D6, Niccolum gluconicum D6, Cobaltum gluconicum D6.

Contains alcohol (30%).

Indications

Adjuvant in the treatment of type I (insulin-dependent) diabetes.

Dosage

10 drops 2-3 times a day.

Package size

30 ml bottle with drop counter. For oral use.

Product link: https://urenus.com/en-us/products/k2f-dia-30ml-drops

(INF gamma, lymphocyte)

Dilution: 4CH

Biological functions: Antiviral activity. NK cell activation. Macrophage activation. Anti-proliferative effects. Enhancing the activity of T lymphocytes.

Uses: Rapid activation of the immune system(activation of the antigen presentation). Stimulation of antiviral defenses. Treatment of autoimmune diseases with risk of viral super-infection. Treatment of hepatitis C and B.

• chronic viral infection
• allergic syndrome
• complementary cancer therapy
• asthenia
• painful muscle spasm

Directions: 15-20 drops two times a day (standard dosage).

Package size: 30 ml/1.0 fl. Oz. bottle with dropper. For oral use.

Product link: https://urenus.com/en-us/products/inf-y-interferon-gamma-lymphocytic-4ch-30ml-drops

Dilution: 4CH

Biological functions: Antiviral activity.

Uses

• recurrent viral infection
• joint pain
• asthenia
• sudden pain with numbness
• painful muscle spasm

Directions: 15-20 drops two times a day (standard dosage).

Package size: 30 ml/1.0 fl. Oz. bottle with dropper. For oral use.

Product link: https://urenus.com/en-us/products/inf-a-interferon-alpha-leukocytic-4ch-30ml-drops

Gunamino Formula marked a turning point in the nutrition field, especially in weight management and clinical nutrition. The scientific history of essential amino acid identification started in 1820, with the discovery of Leucine and continued over the years up to a first important conclusion when, in 1974, the eighth essential amino acid was discovered by W. Rose.

It was then that specific research studies started to establish whether or not there was an ideal combination of specific essential amino acids for the human body. Today, almost two hundred years later, we are in possession of the amino acid profile specific to the human race, which was obtained by studying the relationship of mutual percentage prevalence of the 8 essential amino acids in a very high number of proteins. This knowledge formed the basis for Gunamino Formula, the food supplement containing the 8 essential amino acids in a balanced, ideal combination, specifically studied for use in humans.

The characteristics of Gunamino Formula

Gunamino Formula amino acids are ultrapure, crystallised and of biotechnological origin.

The blend of the 8 essential amino acids is contained in a special proportional relationship, the only one that allows their optimal absorption and maximum use through the anabolic pathway. Amino acid metabolism is self-limiting, i.e. the 8 essential amino acids must be administered simultaneously and in a specific and unique qualitative and quantitative ratio to obtain optimum protein synthesis. The intracellular deficiency of one or more amino acids limits the use of the others, which reduces the protein synthesis rate and increases the production of nitrogen residues.

Gunamino Formula has an excellent safety profile. Only a very small percentage of amino acids follows the catabolic pathway, so that Gunamino Formula:

• Is absorbed within a few minutes, without digestive effort
• Does not produce nitrogenous waste and does not overload the kidneys and liver
• Provides a higher biological protein value than any other food, with the lowest weight and volume
• Provides a minimal calorie intake
• Moreover, it is GMO-free.

Gunamino Formula boasts the highest biological value of protein (BVP), defined as the relationship between withheld and absorbed Nitrogen. The BVP represents the index of nobility of a protein and indicates the nutritional capacity of a protein food or blend of amino acids.

Fields of application

In Dietetics, Gunamino Formula offers unique opportunities, as it allows to reduce fat mass and simultaneously feed lean mass, with a minimal calorie intake. The requisite for weight loss (i.e. in order to obtain a negative energy balance) is perfectly satisfied by Gunamino Formula, which makes it possible to lower the dietary calorie regimen, forcing the body to use the fat mass as a source of energy, at the same time preventing it from attacking the lean mass, which is perfectly nourished by the special blend of amino acids.

The use of Gunamino Formula during weight loss allows to achieve the following results:

• Reducing fat mass
• Protecting the lean mass
• Firming the tissues
• Controlling hunger
• Avoiding the yo-yo effect.

Gunamino Formula is ideal in Clinical Nutrition, both as a tool for primary prevention and for complementary treatment of many medical conditions, particularly chronic-degenerative ones.

Gunamino Formula’s unique characteristics guarantee ideal nutritional conditions in chronic or debilitated patients. Some of the medical conditions Gunamino Formula can be used for include: anaemia, inflammatory bowel diseases, malnutrition, foetal hyposomia, metabolic syndrome, chronic renal insufficiency, ageing.

It guarantees:

• Fast and complete intestinal absorption (with almost no consequent digestive effort)
• The extremely reduced production of nitrogenous waste (without a consequent renal overload)
• A reduction in catabolic processes, with a reduction in the impoverishment of the protein make-up (hormones, cytokines, neuropeptides, as well as muscle and bone mass)
• The maximisation of protein synthesis (with a general benefit for the patient’s strength).

Directions

Sachets: dissolve the content of one sachet in a glass of water (200 ml) or another drink, and stir well.

Tablets: swallow tablets with a little water.

Ingredients

Sachets: Blend of essential amino acids (77%) (L-Leucine, L-Valine, L-Isoleucine, L-Lysine hydrochloride, L-Phenylalanine, L-Threonine, L-Methionine, L-Tryptophan), maltodextrins, acidity regulator: citric acid; flavouring, emulsifier: sucrose esters of fatty acids; sweetener: sucralose.

Tablets: L-Leucine, L-Valine, L-Isoleucine, L-Lysine hydrochloride, L-Phenylalanine, L-Threonine, L- Methionine, L-Tryptophan, coating agents: hydroxypropyl methylcellulose, shellac, E472; bulking agent: microcrystalline cellulose; colouring: E171.

Packaging

Sachets: 24 x 6.5 g sachets – Net weight 156 g 42 x 6.5 g sachets – Net weight 273 g

Tablets: 50 x 1.01 g sachets – Net weight 156 g 150 x 1.01 g sachets – Net weight 273 g

Warnings and precautions

Store away from direct light, in a cool, dry place. The expiry date refers to the product correctly stored in its original and undamaged packaging. Do not exceed the stated recommended daily dose. Keep out of the reach of young children. Food supplements should not be considered as a substitute for a varied diet and a healthy lifestyle.

Most common combinations

Gunamino Formula + Omega Formula: Metabolic syndrome.

Gunamino Formula + Ferroguna: Anemia with low hemoglobin values.

Gunamino Formula + Vit Formula: Malnutrition with vitamin deficiencies.

Gunamino Formula + Colostrononi: Inflammatory Bowel Disease.

Product link: https://urenus.com/en-us/products/gunamino-formula-pack-50-tablets-of-1-4-grams